Identification of a melanoma susceptibility locus and somatic mutation in TET2.
about
Telomere structure and maintenance gene variants and risk of five cancer typesBioinformatics and Drug Discovery.TET2 binds the androgen receptor and loss is associated with prostate cancer.Ascorbate induces apoptosis in melanoma cells by suppressing Clusterin expression.Targeted next-generation sequencing reveals high frequency of mutations in epigenetic regulators across treatment-naïve patient melanomas.Loss of the epigenetic mark, 5-Hydroxymethylcytosine, correlates with small cell/nevoid subpopulations and assists in microstaging of human melanoma.Next generation sequencing of Cytokeratin 20-negative Merkel cell carcinoma reveals ultraviolet-signature mutations and recurrent TP53 and RB1 inactivationAssociations between smoking behavior-related alleles and the risk of melanoma.Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities.TET2 Negatively Regulates Nestin Expression in Human Melanoma.Adult T cell leukemia aggressivenness correlates with loss of both 5-hydroxymethylcytosine and TET2 expression.Genetic variants in the genes encoding rho GTPases and related regulators predict cutaneous melanoma-specific survival.Genetic Variants in Epigenetic Pathways and Risks of Multiple Cancers in the GAME-ON Consortium.Integrative genetic analysis suggests that skin color modifies the genetic architecture of melanoma.Epigenetic dysregulation of TET2 in human glioblastoma.New susceptibility loci for cutaneous melanoma risk and progression revealed using a porcine model.
P2860
Q28397509-2D8D6E50-9C0D-4969-81F7-B49A159FC0B6Q30395256-92BD1BE4-5315-4F97-8D43-4CC304215749Q33563729-6CF7662B-4D61-4E6D-992B-2DD3EA81FE71Q33808109-CA46118C-922A-4451-85FA-0AD6D82604CAQ35896475-84D463D4-57BD-4576-8D70-4445EF3CF7ECQ36545941-EC8EDE66-6DE5-4227-A044-481D7F7513CCQ36625997-921AD164-E2A6-4518-94BE-515CF0616290Q37565142-38E5F934-BE5C-45AC-A39B-0AB242CEB859Q37737945-6239BA91-6C6F-49DF-99C8-00E7A96F2155Q38776330-795B6649-BAE6-476B-BEDB-840FB6844E05Q40053212-77A0ECDE-E76C-4F7F-8CC5-88DED35EE48FQ40199543-24AAF0AB-74F3-4670-AD1E-868980075B39Q40367682-B4C13C52-6A9F-4074-ACFA-0F99AE22149EQ42369632-B4BDEC24-978B-46E9-916A-F3846AA6DE1AQ55287120-8CE76CA4-DFCC-495D-86D9-015DC5649552Q55513422-632B7DA7-C94F-4FA8-AB9D-4DEFA5286BAC
P2860
Identification of a melanoma susceptibility locus and somatic mutation in TET2.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Identification of a melanoma susceptibility locus and somatic mutation in TET2.
@ast
Identification of a melanoma susceptibility locus and somatic mutation in TET2.
@en
Identification of a melanoma susceptibility locus and somatic mutation in TET2.
@en-gb
type
label
Identification of a melanoma susceptibility locus and somatic mutation in TET2.
@ast
Identification of a melanoma susceptibility locus and somatic mutation in TET2.
@en
Identification of a melanoma susceptibility locus and somatic mutation in TET2.
@en-gb
prefLabel
Identification of a melanoma susceptibility locus and somatic mutation in TET2.
@ast
Identification of a melanoma susceptibility locus and somatic mutation in TET2.
@en
Identification of a melanoma susceptibility locus and somatic mutation in TET2.
@en-gb
P2093
P2860
P50
P3181
P356
P1433
P1476
Identification of a melanoma susceptibility locus and somatic mutation in TET2.
@en
P2093
Abrar A Qureshi
Anne E Cust
Fengju Song
GenoMEL consortium
Jeffrey E Lee
Kevin M Brown
Mark M Iles
Neal I Lindeman
Nicholas K Hayward
P2860
P304
P3181
P356
10.1093/CARCIN/BGU140
P407
P50
P577
2014-06-30T00:00:00Z